[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336624-105":59,"doc-detail-336624-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","recent-advancements-in-the-application-of-circulating-tumor-dna-as-biomarkers-for-early-detection-of-cancers","Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers","","Early detection of cancer is essential for improving patient survivability and treatment outcomes. Traditional diagnosis relies on examinations, tissue biopsy, and tumor biomarker detection, but circulating tumor DNA (ctDNA) has attracted strong interest for its high sensitivity, specificity, and noninvasive character. ctDNA arises from tumor cell processes such as apoptosis, necrosis, and exosome release, enabling detection of methylations, mutations, rearrangements, and microsatellite instability. The review emphasizes biosensor approaches that support real-time, portable, and rapid ctDNA measurement.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/recent-advancements-in-the-application-of-circulating-tumor-dna-as-biomarkers-for-early-detection-of-cancers/336624/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/recent-advancements-in-the-application-of-circulating-tumor-dna-as-biomarkers-for-early-detection-of-cancers/336624.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is early cancer detection important?","Question",{"text":112,"@type":113},"Early detection increases survival chances by enabling treatment when disease is more localized and less likely to have spread. It can improve outcomes for surgery, chemotherapy, and radiation, while reducing adverse effects and healthcare costs.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What makes circulating tumor DNA (ctDNA) useful as a biomarker?",{"text":117,"@type":113},"ctDNA is noninvasive and reflects tumor-derived genetic material in the circulation. It can be analyzed to track disease progression, predict therapy response, and detect minimal residual illness or relapse.",{"name":119,"@type":110,"acceptedAnswer":120},"How does ctDNA relate to molecular changes detected in blood?",{"text":121,"@type":113},"ctDNA spreads through the circulatory system after tumor cell processes such as apoptosis, necrosis, and exosome release. It carries modifications including DNA methylations, mutations, gene rearrangements, and microsatellite instability.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336624,1790119384,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","This article is licensed under CC-BY 4.0   \n[pubs.acs.org/journal/abseba](pubs.acs.org/journal/abseba)  Review   \nRecent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers  \nMahima Mishra, Rubai Ahmed, Deepak Kumar Das, Devlina Das Pramanik, Sandeep Kumar Dash, and Arindam Pramanik*  \n Cite This: ACS Biomater. Sci. Eng. 2024, 10, 4740−4756  \nRead Online  \n\n|  |  |  |  |\n| --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |\n\nABSTRACT: Early detection of cancer is vital for increasing patient survivability chances. The three major techniques used to diagnose cancers are instrumental examination, tissue biopsy, and tumor biomarker detection. Circulating tumor DNA (ctDNA) has gained much attention in recent years due to advantages over traditional technology, such as high sensitivity, high specificity, and noninvasive nature. Through the mechanism of apoptosis, necrosis, and circulating exosome release in tumor cells, ctDNA can spread throughout the circulatory system and carry modifications such as methylations, mutations, gene rearrangements, and microsatellite instability. Traditional gene-detection technology struggles to achieve real-time, low-cost, and portable ctDNA measurement,  \nwhereas electrochemical biosensors offer low cost, high specificity alongside sensitivity, and portability for the detection of ctDNA. Therefore, this review focuses on describing the recent advancements in ctDNA biomarkers for various cancer types and biosensor developments for real-time, noninvasive, and rapid ctDNA detection. Further in the review, ctDNA sensors are also discussed in regards to their selections of probes for receptors based on the electrode surface recognition elements.  \nKEYWORDS: Circulating tumor DNA, Cell free DNA, Cancer Biomarker, DNA methylation, DNA probes, RNA probes  \n1. INTRODUCTION  \nEarly cancer detection is critical for increasing survival and treatment outcomes. When cancer is detected at an early stage, it is often more localized and less likely to have spread to other parts of the body, making treatment more successful.1 This early intervention may significantly improve the success rate of treatments like as surgery, chemotherapy, and radiation therapy, while also minimizing the severity and duration of adverse effects.1 Furthermore, early detection of cancer can reduce total healthcare costs and enhance patients’ quality of life by allowing for less aggressive therapy and minimizing the  \npsychological and physical burden of advanced disease.2  \nAlthough early cancer diagnosis and detection can be difficult, it is now possible due to advancement in molecular biomarkers. To identify molecular signatures such as genetic and epigenetic changes in gene expression as well as protein expression, numerous genomic and proteomic techniques are being used. Such techniques include real-time PCR, DNA sequencing, microarrays, molecular tests, endoscopy,biopsy, artificial intelligence, and machine learning.3 Early in the course of the disease, many malignant tumors release intracellular molecules, whole cells or pieces of cells into the surrounding environment. These compounds can frequently be found in the blood, body fluids, or feces, which opens the door  \nto simpler, less invasive screening techniques for the early detection of cancer. Liquid biopsies have recently gained popularity among researchers due to their noninvasive, rapid, and comprehensive nature.2 These liquid biopsies include detection of circulating tumor cells (CTCs), circulating tumor  \nDNA (ctDNA), and circulating cell-free DNA (cfDNA).  \nTumor cell DNA circulating in the blood, commonly referred to as circulating tumor DNA, or ctDNA, is one kind of biomarker that has attracted much attention. Because of its distinct features and benefits, ctDNA testing stands out among early cancer detection approaches.4 Unlike typical diagnostic tests, ctDNA testing is a noninvasive way","cbCaiaqVpJ2wdQZA","https://ap.wps.com/l/cbCaiaqVpJ2wdQZA","pdf",14247864,17,"English","# Abstract\n# Introduction\n# Utilizing ctDNA in Cancer Diagnosis and Biomarkers in Various Cancers\n## Head and Neck Squamous Cell Carcinoma","[{\"question\":\"Why is early cancer detection important?\",\"answer\":\"Early detection increases survival chances by enabling treatment when disease is more localized and less likely to have spread. It can improve outcomes for surgery, chemotherapy, and radiation, while reducing adverse effects and healthcare costs.\"},{\"question\":\"What makes circulating tumor DNA (ctDNA) useful as a biomarker?\",\"answer\":\"ctDNA is noninvasive and reflects tumor-derived genetic material in the circulation. It can be analyzed to track disease progression, predict therapy response, and detect minimal residual illness or relapse.\"},{\"question\":\"How does ctDNA relate to molecular changes detected in blood?\",\"answer\":\"ctDNA spreads through the circulatory system after tumor cell processes such as apoptosis, necrosis, and exosome release. It carries modifications including DNA methylations, mutations, gene rearrangements, and microsatellite instability.\"}]","Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers | PDF",1790015914,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fcea531970a3bce324ab156ca00645c9.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3189a4a7daed9e5756de7064fff7c6fa.webp",982,1295,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/038504d02cc4e8fd7c642f009f265abb.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/46da4cf6082e4e45bab72d3638c614a8.webp",980,1292]